SCHEMBL14748435

SCHEMBL14748435

Cc1ccc(Cl)nc1Oc1ccc(Br)c(C=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
MERTK Q12866 1/20 0.36
HAO1 Q9UJM8 1/20 0.35
CYP2C19 P33261 6/20 0.33
CYP1A2 P05177 5/20 0.33
CYP2C9 P11712 4/20 0.33
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP3A4 P08684 3/20 0.33
CYP2D6 P10635 1/20 0.33
PRKDC P78527 1/20 0.33
ALDH1A1 P00352 5/20 0.32
GAA P10253 1/20 0.32
SMN1; SMN2 Q16637 3/20 0.31
KDM4E B2RXH2 2/20 0.31
MPI P34949 1/20 0.31
ERN1 O75460 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14748436 0.83 PRKDC (0.43) CRHBPCRHR2CYP2C19CYP1A2MEN1
SCHEMBL19622180 0.82 HAO1 (0.33) HAO1CYP2C19CYP1A2CYP2C9CYP3A4
SCHEMBL2232778 0.81 KDM4E (0.41) CRHBPCRHR2MERTKCYP2C19CYP1A2
SCHEMBL19622260 0.78 CTSC (0.38) CYP1A2MAPTL3MBTL1ALDH1A1GAA
SCHEMBL24060727 0.77 LMNA (0.40) HAO1MEN1MAPTKMT2AL3MBTL1
SCHEMBL19622259 0.74 LMNA (0.41) MAPTL3MBTL1PRKDCALDH1A1GAA
SCHEMBL7863855 0.72 HTT (0.44) CYP2C19CYP1A2CYP2C9MEN1MAPT
SCHEMBL29746806 0.72 HTT (0.44) CYP2C19CYP1A2CYP2C9MEN1MAPT
SCHEMBL23243708 0.72 MERTK (0.54) CRHBPCRHR2MERTKMEN1MAPT
SCHEMBL25590230 0.70 PPARG (0.39) HAO1MAPTL3MBTL1PRKDCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2564857-A1 Boron-containing small molecules as anti-inflammatory agents Anacor Pharmaceuticals, Inc. (US) 2013-03-06 EP disclosed